Wells Fargo lowered the firm’s price target on Bruker (BRKR) to $75 from $78 and keeps an Overweight rating on the shares. The silver lining in the second half of the year guide reset is that 2025 consensus numbers should rebase lower, which removes an overhang for investors.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR: